{
    "root": "85899b95-661f-4027-9760-31a6fd175ff0",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Diclofenac sodium and Misoprostol",
    "value": "20250522",
    "ingredients": [
        {
            "name": "DICLOFENAC SODIUM",
            "code": "QTG126297Q",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4509"
        },
        {
            "name": "MISOPROSTOL",
            "code": "0E43V0BB57",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_63610"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "HYDROGENATED CASTOR OIL",
            "code": "ZF94AP8MEY",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_140618"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_168426"
        }
    ],
    "indications": {
        "text": "diclofenac sodium/misoprostol indicated treatment signs symptoms osteoarthritis rheumatoid arthritis adult patients high risk developing nsaid-induced gastric duodenal ulcers complications . list factors may increase risk nsaid-induced gastric duodenal ulcers complications [ ( 5.3 ) ] .",
        "doid_entities": [
            {
                "text": "osteoarthritis (DOID:8398)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8398"
            },
            {
                "text": "rheumatoid arthritis (DOID:7148)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7148"
            },
            {
                "text": "arthritis (DOID:848)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_848"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 lowest effective shortest duration consistent individual patient treatment goals . ( 2.1 ) \u2022 osteoarthritis : recommended maximal gi protection one tablet ( containing 50 mg diclofenac 200 mcg misoprostol ) three times daily . diclofenac higher 150 mg/day recommended . ( 2.2 ) \u2022 rheumatoid arthritis : recommended maximal gi protection one tablet ( containing 50 mg diclofenac 200 mcg misoprostol ) three four times daily diclofenac higher 200 mg/day recommended . ( 2.3 ) \u2022 modifications due intolerance , full prescribing information . ( 2.2 , 2.3 )",
        "doid_entities": [
            {
                "text": "osteoarthritis (DOID:8398)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8398"
            },
            {
                "text": "rheumatoid arthritis (DOID:7148)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7148"
            },
            {
                "text": "arthritis (DOID:848)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_848"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "diclofenac sodium misoprostol delayed-release tablets supplied : \u202250 mg diclofenac sodium 200 mcg misoprostol round , biconvex , white off-white tablets imprinted `` 50 `` middle one side `` g `` `` 0028 `` . \u202275 mg diclofenac sodium 200 mcg misoprostol round , biconvex , white off-white tablets imprinted `` 75 `` middle one side `` g `` `` 0029 `` . strengths supplied : strength ndc number size diclofenac sodium/misoprostol 50 50 mg diclofenac sodiumand200 mcg misoprostol 59762-0028-1 bottle 60 59762-0028-2 bottle 90 diclofenac sodium/misoprostol 75 75 mg diclofenac sodiumand200 mcg misoprostol 59762-0029-1 bottle 60",
    "adverseReactions": "diclofenac sodium/misoprostol contraindicated following patients : \u2022 pregnancy . misoprostol , component diclofenac sodium/misoprostol , pregnancy result maternal fetal harm , including uterine rupture , abortion , premature birth , birth defects [ ( 5.1 ) ( 8.1 ) ] \u2022in setting coronary artery bypass graft ( cabg ) surgery [ ( 5.2 ) ] \u2022active gastrointestinal bleeding [ ( 5.3 ) ] \u2022history asthma , urticaria , allergic-type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids reported patients [ ( 5.8 , 5.9 ) ] \u2022known hypersensitivity ( e.g . , anaphylactic serious skin ) diclofenac sodium misoprostol , prostaglandins , components product [ ( 5.8 , 5.10 ) ]",
    "indications_original": "Diclofenac sodium/misoprostol is indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in adult patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications. For a list of factors that may increase the risk of NSAID-induced gastric and duodenal ulcers and their complications [see Warnings and Precautions (5.3)].",
    "contraindications_original": "\u2022 Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals. ( 2.1 ) \u2022 Osteoarthritis: The recommended dosage for maximal GI protection is one tablet (containing 50\u00a0mg of diclofenac and 200\u00a0mcg of misoprostol) three times daily. A dosage of diclofenac higher than 150\u00a0mg/day is not recommended. ( 2.2 ) \u2022 Rheumatoid Arthritis: The recommended dosage for maximal GI protection is one tablet (containing 50\u00a0mg of diclofenac and 200\u00a0mcg of misoprostol) three or four times daily A\u00a0dosage of diclofenac higher than 200\u00a0mg/day is not recommended. ( 2.3 ) \u2022 For dosage modifications due to intolerance, see the full Prescribing Information. ( 2.2 , 2.3 )",
    "warningsAndPrecautions_original": "Diclofenac sodium and misoprostol delayed-release tablets are supplied as:\n                  \n                     \n                        \u202250 mg diclofenac sodium and 200 mcg misoprostol as round, biconvex, white to off-white tablets imprinted with a \"50\" in the middle on one side and \"G\" and \"0028\" on the other.\n                     \n                        \u202275 mg diclofenac sodium and 200 mcg misoprostol as round, biconvex, white to off-white tablets imprinted with a \"75\" in the middle on one side and \"G\" and \"0029\" on the other.\n                  \n                  The dosage strengths are supplied in:\n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Strength\n                              \n                           \n                           \n                              \n                                 NDC Number\n                              \n                           \n                           \n                              \n                                 Size\n                              \n                           \n                        \n                        \n                           \n                              Diclofenac sodium/misoprostol 50\n                           \n                           \n                              50 mg diclofenac sodiumand200 mcg misoprostol\n                           \n                           \n                              59762-0028-1\n                           \n                           \n                              bottle of 60\n                           \n                        \n                        \n                           \n                              59762-0028-2\n                           \n                           \n                              bottle of 90\n                           \n                        \n                        \n                           \n                              Diclofenac sodium/misoprostol 75\n                           \n                           \n                              75 mg diclofenac sodiumand200 mcg misoprostol\n                           \n                           \n                              59762-0029-1\n                           \n                           \n                              bottle of 60",
    "adverseReactions_original": "Diclofenac sodium/misoprostol is contraindicated in the following patients:\n                  \n                     \n                        \u2022\n                        Pregnancy. Use of misoprostol, a component of diclofenac sodium/misoprostol, during pregnancy can result in maternal and fetal harm, including uterine rupture, abortion, premature birth, or birth defects [see Warnings and Precautions (5.1) and Use in Specific Populations (8.1)]\n                        \n                     \n                     \n                        \u2022In the setting of coronary artery bypass graft (CABG) surgery [see Warnings and Precautions (5.2)]\n                     \n                     \n                        \u2022Active gastrointestinal bleeding [see Warnings and Precautions (5.3)]\n                     \n                     \n                        \u2022History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.8, 5.9)]\n                     \n                     \n                        \u2022Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac sodium and misoprostol, other prostaglandins, or any components of the drug product [see Warnings and Precautions (5.8, 5.10)]",
    "drug": [
        {
            "name": "Diclofenac sodium and Misoprostol",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_47381"
        }
    ]
}